Skip to content
healthcare.dev

Potassium Citrate

NDC 0591-2742, Potassium Citrate, tablet, extended release, from Actavis Pharma, Inc..

Product NDC
0591-2742
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209758
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2742 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CITRATE15 meq/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
0591-2742-0100591274201100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2742-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac173781-486b-461c-97ae-8b5c69e20792
  • NADAC price for package 00591274201

    GET /v1/drugs/nadac/00591274201

Use it

Look up 0591-2742 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2742 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2742. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.